Please assess the completion status of the following clinical trial:

Trial Title: Caffeine and Intermittent Claudication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* men and women \> 40 years~* history of IC of the lower extremities, Fontaine II~* ankle-brachial index (ABI)\> 0.9 (subjects who are referred for a revasularizarition procedure)~Exclusion Criteria:~* dementia~* diabetes~* illness or reason to be unable to participate, f.ex. general weakness, amputation or arthritis~* acute illness, f.ex. inflammation, unstable angina~* other reasons which contraindicate participation/treadmill exercise~* intake of Trental and/or Teofyllamin~* weight \> 100kg

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).